Available Until 2/8/2024

Adding It All Up: Cost-effectiveness Considerations for Ready-to-Administer IV Push Products

Content Release Date: 2/8/2023
Expiration Date: 2/8/2024
Activity Type: Application-based
CE Credits: up to 1.5 contact hours (0.15 CEUs)
Activity Fee:  Free

Activity Overview

Patient safety is always a primary concern, but outside factors, including additional stress caused by COVID-19 and diversion of controlled substances, have added challenges to IV medication processes. Complicating matters is that the true costs of safety of IV drug delivery systems are unknown and extend well beyond the cost of acquiring these technologies. This educational activity will review the peer-reviewed literature relating to the selection and use of manufacturer-prepared ready-to-administer (RTA) and traditional vial products on the basis of safety, waste, and workforce considerations. The importance of incorporating cost-effectiveness data into purchasing decisions will also be described as they relate to improving care, reducing diversion, enhancing patient safety, and maximizing resources. 

*Please note, this activity was presented live on December 6, 2022 as part of the ASHP 2022 Midyear Clinical Meeting & Exhibition. You can only claim credit once for this activity; live or home study

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This activity was planned to meet the educational needs of pharmacists, especially chief pharmacy officers, pharmacy leaders and administrators, medication safety and compliance officers, and procurement managers who work in hospitals and health systems.  

After participating in this CPE activity, learners should be able to:

ACPE Number: 0204-0000-22-427-H04-P

  • Evaluate peer-reviewed literature that relates to the selection and use of manufacturer-prepared ready to administer (RTA) and traditional IV vial products.
  • Explain the importance of incorporating cost-effectiveness data in the selection of IV push products.
  • Identify the impact of integrating and adopting manufacturer-prepared RTA syringes within a health-system.  

John B. Hertig, PharmD, MS, CPPS, FASHP, FFIP, Activity Chair
Associate Professor and Department Chair
Butler University College of Pharmacy and Health Sciences
Indianapolis, Indiana 

More information on John B. Hertig
John B. Hertig, PharmD, MS, CPPS, FASHP is Vice-Chair and an Associate Professor of Pharmacy Practice in the Butler University College of Pharmacy and Health Sciences. Dr. Hertig lectures around the world and publishes on a variety of patient safety, leadership, administration, health policy topics. Dr. Hertig is a Member of the United States FDA Drug Safety and Risk Management Advisory Committee. He holds other national and international appointments, including with the International Pharmaceutical Federation, where he is Vice President of the Americas for the Hospital Pharmacy Section, and as President of the Board of Directors for the Alliance for Safe Online Pharmacies – Global (ASOP), where he leads efforts to reduce the patient safety impact of illegal and counterfeit online drug distribution worldwide.  He was awarded the ASOP Global Patient Safety Champion Award in 2018.  Dr. Hertig received his Bachelor of Science in Pharmaceutical Sciences and Doctor of Pharmacy degrees from Purdue University. He completed a PGY1 pharmacy practice and PGY2 health-system pharmacy administration residency at The Ohio State University Medical Center while also obtaining a Masters degree in Health-System Pharmacy Administration from The Ohio State University.   


Ryan Haumschild, PharmD, MS, MBA
Director of Pharmaceutical Services
Emory Healthcare
Winship Cancer Institute
Atlanta, Georgia 

More information on Ryan Haumschild

Ryan Haumschild PharmD, MS, MBA, is currently the Director of Pharmacy at Emory Healthcare in Atlanta, GA. Ryan completed is undergraduate studies at the University of Central Florida and then obtained his Masters of Business Administration from South University before completing pharmacy school at the University of Florida. After receiving his doctorate of pharmacy Ryan completed a PGY1/PGY2 residency in Health System Pharmacy Administration at The Ohio State University Wexner Medical Center while obtaining his Master’s Degree in Health Services Pharmacy Administration from The Ohio State University. Dr. Haumschild has oversight for oncology and infusion pharmacy services, retail and specialty pharmacies, finance and 340B program, ambulatory surgical centers, and clinical pharmacy services. He has expertise in controlled substance management and hazardous drug handling.  He also has responsibility within Emory Healthcare and throughout the drug supply chain for pathway development and product utilization. He has completed and published research around medication safety, specialty pharmacy, pharmacy leadership, hazardous drug compounding, and integrated facility design. 


Jeffery S. Vender, MD, MCCM, FCCP
Emeritus, Harris Family Foundation Chairman
Department of Anesthesia
NorthShore University HealthSystem
Clinical Professor Anesthesiology
University of Chicago, Pritzker School of Medicine 

Jeffery S. Vender, MD, MCCM, MBA is the Emeritus, Harris Family Foundation Chairman of the Department of Anesthesiology at NorthShore University Health System in Evanston, Illinois and a Clinical Professor at the University of Chicago Pritzker School Of Medicine in Chicago, Illinois. He is a past member of the NorthShore University Health System Faculty Practice Associates Board of Directors, Past Chair of the Medical Executive Committee for the Professional Staff at NorthShore and previously served on Northshore’s Board of Directors. Dr. Vender served as Chair of Anesthesia from 1990-2015 and received an appointment of adjunct Professor of Biomedical Engineering at Northwestern University. He served as the Director of the Critical Care Services at Evanston Hospital from 1987-2000 and the Interim Chairman at Northwestern University Department of Anesthesiology from July 1999 until October 2000. Dr. Vender has participated and Chaired numerous state and national committees of various medical organizations, edited several medical texts, has published over 135 articles and book chapters and has been an invited lecturer at over 250 national and international meetings on topics of anesthesiology, critical care, organizational change, and leadership. In addition, Dr. Vender serves as an editor and/or reviewer for many medical journals. 

The following persons in control of this activity’s content have relevant financial relationships:

  • John B. Hertig ‐ Principal Investigator, Fresenius Kabi
  • Jeffery S. Vender ‐ Consultant, Fresenius Kabi 

All other persons in control of content do not have any relevant financial relationships with an ineligible company. 

As defined by the Standards of Integrity and Independence in Accredited Education definition of ineligible company. All relevant financial relationships have been mitigated prior to the CE activity.

Activities can be completed in any order. Each activity consists of audio, video and an evaluation. Learners must review all content and complete an evaluation to receive continuing education credit for each activity.

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned – no exceptions! To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, we encourage you to check your NABP eProfile account to validate your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.

Provided by ASHP
Supported by an educational grant from Fresenius Kabi USA, LLC